Medios AG (OTCMKTS:MEDOF) Stock Short Interest Report for September

Posted by George Bondi on Oct 10th, 2026

Medios AG (OTCMKTS:MEDOF – Get Free Report) saw a significant growth in short interest during the month of September. As of September 30th, there was short interest totaling 858 shares, a growth of 1,200.0% from the September 15th total of 66 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

Medios Stock Performance

MEDOF stock remained flat at C$13.64 during trading on Friday. The business has a fifty day moving average of C$13.64 and a 200-day moving average of C$13.64. Medios has a 12-month low of C$13.64 and a 12-month high of C$13.64.

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Medios in a report on Thursday, August 13th. One analyst has rated the stock with a Buy rating. Based on data from MarketBeat.com, the stock has an average rating of “Buy”.

Get Our Latest Stock Report on Medios

Medios Company Profile

(Get Free Report)

Medios AG is a Germany-based specialty pharmaceutical company that supplies medicines and related services for patients with complex, chronic and rare diseases. The company works primarily with pharmacies, medical providers and other healthcare partners, supporting the delivery of therapies that often require specialized handling and coordination.

Its activities include the pharmaceutical supply of specialty medicines and the preparation of patient-specific therapies. Medios focuses on areas such as oncology, autoimmune diseases, neurology and other conditions in which individualized treatment solutions or close pharmaceutical support may be required.

Based in Berlin, Medios serves the German healthcare market through its specialty pharmaceutical platform and pharmacy network.